MorphoSys AG To Start Share Buy-Back Program

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MARTINSRIED / MUNICH, Germany, March 3, 2014 (GLOBE NEWSWIRE) -- The Executive Board of MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today announced the decision to repurchase up to 111,000 of its own shares over the stock market during the time period from 4 March 2014 to 28 March 2014, based on the authorization of the Annual General Meeting on May 19, 2011. This represents up to 0.42% of the registered share capital of the Company. On the basis of the current share price (EUR 67.28; Xetra closing price as of 28 February 2014), the value of the share buy-back program amounts to around EUR 7.5 million (excluding ancillary costs).

Help employers find you! Check out all the jobs and post your resume.

Back to news